Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Viruses
Entry Details
ID
3286
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
Q9QSQ7 (Created: 2006-06-27 Updated: 2008-11-25)
UniProtKB/Swiss-Prot Entry Name
ENV_HV1VI
Protein Name
Envelope glycoprotein gp160
Gene
env
Organism Scientific
Human immunodeficiency virus type 1 (isolate VI850 group M subtype F1)
Organism Common
HIV-1
Lineage
Viruses
Retro-transcribing viruses
Retroviridae
Orthoretrovirinae
Lentivirus
Primate lentivirus group
Protein Length [aa]
832
Protein Mass [Da]
93810
Features
Type
Description
Status
Start
End
signal peptide
by similarity
1
31
chain
Envelope glycoprotein gp160
by similarity
32
832
chain
Surface protein
by similarity
32
487
chain
Transmembrane protein
by similarity
488
832
disulfide bond
by similarity
53
73
disulfide bond
by similarity
118
196
disulfide bond
by similarity
125
187
disulfide bond
by similarity
130
147
disulfide bond
by similarity
209
238
disulfide bond
by similarity
219
230
disulfide bond
by similarity
287
321
disulfide bond
by similarity
368
422
disulfide bond
by similarity
375
395
transmembrane region
potential
661
681
topological domain
Extracellular
potential
32
660
topological domain
Cytoplasmic
potential
682
832
region of interest
V1
130
146
region of interest
V2
147
187
region of interest
V3
287
320
region of interest
V4
375
395
region of interest
V5
438
447
region of interest
Fusion peptide
potential
488
508
region of interest
Immunosuppression
by similarity
552
568
region of interest
Involved in GalCer binding
by similarity
638
643
glycosylation site
N-linked (GlcNAc...)
potential
87
87
glycosylation site
N-linked (GlcNAc...)
potential
129
129
glycosylation site
N-linked (GlcNAc...)
potential
132
132
glycosylation site
N-linked (GlcNAc...)
potential
135
135
glycosylation site
N-linked (GlcNAc...)
potential
146
146
glycosylation site
N-linked (GlcNAc...)
potential
150
150
glycosylation site
N-linked (GlcNAc...)
potential
177
177
glycosylation site
N-linked (GlcNAc...)
potential
178
178
glycosylation site
N-linked (GlcNAc...)
potential
188
188
glycosylation site
N-linked (GlcNAc...)
potential
225
225
glycosylation site
N-linked (GlcNAc...)
potential
232
232
glycosylation site
N-linked (GlcNAc...)
potential
253
253
glycosylation site
N-linked (GlcNAc...)
potential
267
267
glycosylation site
N-linked (GlcNAc...)
potential
280
280
glycosylation site
N-linked (GlcNAc...)
potential
286
286
glycosylation site
N-linked (GlcNAc...)
potential
292
292
glycosylation site
N-linked (GlcNAc...)
potential
322
322
glycosylation site
N-linked (GlcNAc...)
potential
329
329
glycosylation site
N-linked (GlcNAc...)
potential
345
345
glycosylation site
N-linked (GlcNAc...)
potential
352
352
glycosylation site
N-linked (GlcNAc...)
potential
382
382
glycosylation site
N-linked (GlcNAc...)
potential
388
388
glycosylation site
N-linked (GlcNAc...)
potential
419
419
glycosylation site
N-linked (GlcNAc...)
potential
425
425
glycosylation site
N-linked (GlcNAc...)
potential
437
437
glycosylation site
N-linked (GlcNAc...)
potential
587
587
glycosylation site
N-linked (GlcNAc...)
potential
592
592
glycosylation site
N-linked (GlcNAc...)
potential
601
601
glycosylation site
N-linked (GlcNAc...)
potential
613
613
site
Cleavage; by host furin
by similarity
487
488
short sequence motif
YXXL motif; contains endocytosis signal
by similarity
688
691
lipid moiety-binding region
S-palmitoyl cysteine; by host
by similarity
740
740
coiled-coil region
potential
518
568
coiled-coil region
potential
609
643
SP Length
31
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MRVRGMQRNWQHLGKWGLLFLGILIICNAAD
Sequence
MRVRGMQRNWQHLGKWGLLFLGILIICNAAD
NLWVTVYYGVPVWKEATTT
LFCASDAKAYEREAHNVWATHACVPTDPNPQEVFLK
N
VTENFDMWKNNMV
EQMHTDIISLWDQSLKPCVKLTPLCVTL
N
CT
N
AT
N
NSQEKPGAMQ
N
CSF
N
MTTEVRDKKLKLSALFYRLDIVPIGN
N
N
SSEYRLINC
N
TSTITQACPKVS
WDPIPIHYCAPAGYAILKCNDKRF
N
GTGPCK
N
VSTVQCTHGIKPVVSTQL
LL
N
GSLAEEGIVIRSQ
N
ISNNAKTIIVHL
N
ESVQI
N
CTRPN
N
NTRKGIHL
GPGQTFYATGAIIGDIRKAH
C
N
ISGTQW
N
NTLEYVKAELKSHFP
N
NTAIK
F
N
QSSGGDLEITMHSFNCRGEFFY
CDTSGLF
N
DTGSN
N
GTITLPC
RIKQI
VNMWQGVGRAMYTSPIAG
N
ITCNS
N
ITGLLLTRDGG
N
ESNIETFRPE
GGN
MKDNWRSELYKYKVVEIEPLGVAPTKAKRQVVQREK
RA
AGLGALFLGFLG
DSREHMGA
ASITLTVQA
RQLLSGIVQQQNNLLRAIEAQQHLLQLTVWGIK
QLQARVLAVERYLKDQQL
LGIWGCSGKLICTTNVPW
N
SSWS
N
KSQEEIWN
N
MTWMEWE
KEISNYSNIIYKLIEESQNQQEKNEQELLALDKWA
SLWNWFD
ISNWLWYIKI
FIMIVGGLIGLRIVFAVLSIV
NRVRKG
YSPL
SLQTLIPSP
RGPDRPEGIEEGGGEQGKDRSVRLVTGFLALAWDDLRNL
C
LFSYRHLRDF
ILIAARIVDRGLRRGWEALKYLGNLTRYWSQELKNSAISLFNTTAIVVAE
GTDRIIEVLQRAGRAVLNIPRRIRQGAERALL
Original
MRVRGMQRNWQHLGKWGLLFLGILIICNAADNLWVTVYYGVPVWKEATTT
LFCASDAKAYEREAHNVWATHACVPTDPNPQEVFLKNVTENFDMWKNNMV
EQMHTDIISLWDQSLKPCVKLTPLCVTLNCTNATNNSQEKPGAMQNCSFN
MTTEVRDKKLKLSALFYRLDIVPIGNNNSSEYRLINCNTSTITQACPKVS
WDPIPIHYCAPAGYAILKCNDKRFNGTGPCKNVSTVQCTHGIKPVVSTQL
LLNGSLAEEGIVIRSQNISNNAKTIIVHLNESVQINCTRPNNNTRKGIHL
GPGQTFYATGAIIGDIRKAHCNISGTQWNNTLEYVKAELKSHFPNNTAIK
FNQSSGGDLEITMHSFNCRGEFFYCDTSGLFNDTGSNNGTITLPCRIKQI
VNMWQGVGRAMYTSPIAGNITCNSNITGLLLTRDGGNESNIETFRPEGGN
MKDNWRSELYKYKVVEIEPLGVAPTKAKRQVVQREKRAAGLGALFLGFLG
DSREHMGAASITLTVQARQLLSGIVQQQNNLLRAIEAQQHLLQLTVWGIK
QLQARVLAVERYLKDQQLLGIWGCSGKLICTTNVPWNSSWSNKSQEEIWN
NMTWMEWEKEISNYSNIIYKLIEESQNQQEKNEQELLALDKWASLWNWFD
ISNWLWYIKIFIMIVGGLIGLRIVFAVLSIVNRVRKGYSPLSLQTLIPSP
RGPDRPEGIEEGGGEQGKDRSVRLVTGFLALAWDDLRNLCLFSYRHLRDF
ILIAARIVDRGLRRGWEALKYLGNLTRYWSQELKNSAISLFNTTAIVVAE
GTDRIIEVLQRAGRAVLNIPRRIRQGAERALL
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11